Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  edatrexate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 49 for your search:
Start Over
Phase III Comparison of MITO/VBL with vs without EDAM in the Treatment of Stage III/IV non-Small Cell Lung Cancer (Summary Last Modified 04/91)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CG-10-EDAM, NCI-V90-0130
Phase I/II Pilot Study of EMV (EDAM/Mitomycin/Vinblastine) in Patients with Stage III/IV non-Small Cell Lung Cancer (Summary Last Modified 06/89)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-87053A, NCI-V88-0577
Phase I/II Study of Edatrexate in Advanced Breast Cancer and Other Advanced Malignancies (Summary Last Modified 12/2001)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-CCG-921, NCI-T92-0171O, T92-0171
Phase II Study of EDAM Administered Weekly for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix (Summary Last Modified 07/94)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-93149, NCI-T94-0027D, T94-0027
Phase II Study of EDAM for Advanced Soft Tissue Sarcoma (Summary Last Modified 10/2001)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-3793, E3793
Phase II Study of Edatrexate/Vinblastine/Doxorubicin/Cisplatin with G-CSF in Advanced non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-952452, NCCTG-95-24-52
Phase II Study of EDAM in Patients with Metastatic or Locally Inoperable Breast Cancer (Summary Last Modified 09/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND60, NCI-T90-0128O, T90-0128, IND60
Phase II Chemotherapy with EDAM in Patients with Stage IIIB/IV non-Small Cell Lung Cancer (Summary Last Modified 06/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MDA-DM-87086, NCI-V88-0339
Phase II Chemotherapy with EDAM in Patients with Advanced Sarcoma (Summary Last Modified 11/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-87046A1, NCI-T89-0134D, T89-0134
Phase II Study of CDDP/CTX/EDAM in Patients with Stage IIIB/IV non-Small Cell Lung Cancer (Summary Last Modified 05/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MDA-DM-88088, NCI-V89-0030
Phase II Study of EDAM in Patients with Recurrent or Metastatic Soft Tissue Sarcoma (Summary Last Modified 09/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND55, NCI-T90-0083O, T90-0083, IND55
Phase II Trial of EDAM in Patients with Metastatic Colorectal Cancer (Summary Last Modified 05/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: IOWA-902, NCI-T90-0147O, T90-0147
Phase II Study of EDAM in Previously Treated Patients with Extensive or Limited Stage Small Cell Lung Cancer (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-902051, MAYO-902051, NCCTG-90-20-51
Phase II Evaluation of EDAM in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 02/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9046
Phase II Study of EDAM in Patients with Metastatic Malignant Melanoma (Summary Last Modified 03/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 to 70
Sponsor: NCI
Protocol IDs: CAN-NCIC-IND61, NCI-T90-0202O, T90-0202, IND61
Phase II Study of EDAM in the Treatment of Relapsed Metastatic Breast Cancer (Summary Last Modified 12/94)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-90086, NCI-T90-0206D, T90-0206
Phase II Study of EDAM in Patients with Advanced Cervical Cancer (Summary Last Modified 04/1999)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: OSP-90320, NCI-T90-0165O, T90-0165
A Phase II Study of EDAM in Patients with Advanced Pancreatic or Periampullary Cancer (Summary Last Modified 06/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-91016, NCI-T91-0035D, T91-0035
Phase II Study of EDAM in Previously Treated Patients with Small Cell Lung Cancer (Summary Last Modified 10/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-91052, NCI-T91-0012D, T91-0012
Phase II Study of EDAM in Patients with Extensive Stage Small Cell Lung Cancer (Summary Last Modified 08/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-90044, NCI-T90-0117C, T90-0117
Phase II Study of EDAM in Hepatocellular Carcinoma (Summary Last Modified 08/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-91025, NCI-T91-0082C, T91-0082
Phase II Study of EDAM in Patients with Metastatic or Locally Advanced Pancreatic Adenocarcinoma (Summary Last Modified 08/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-91027, NCI-T91-0083C, T91-0083
Phase II Study of EDAM in Patients with Metastatic or Recurrent Bladder Carcinoma (Summary Last Modified 12/92)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-9101
Phase II Study of CBDCA/EDAM with CF Rescue in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 11/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-DM-91042, NCI-T91-0105D, T91-0105
Start Over